XML 78 R23.htm IDEA: XBRL DOCUMENT
v2.4.1.9

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS | 12 Months Ended
--- | ---
Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract] |
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS | SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS
| Balance at Beginning of Period |  | Charged to Costs and Expenses |  | Charged to Other Accounts (1) |  | Deductions |  | Balance at End of Period
Description |  |  |  |
| (In thousands) |  |
Year ended December 31, 2014: |  |  |  |  |  |  |  |  |
Allowance for doubtful accounts and sales returns and allowances | $ | 6,194 |  |  | 1,944 |  |  | — |  |  | (1,954 | ) |  | $ | 6,184 |
Deferred tax asset valuation allowance (As adjusted)* | 9,060 |  |  | (1,102 | ) |  | — |  |  | (698 | ) |  | 7,260 |
Year ended December 31, 2013: |  |  |  |  |  |  |  |  |
Allowance for doubtful accounts and sales returns and allowances | $ | 7,221 |  |  | $ | 601 |  |  | $ | — |  |  | $ | (1,628 | ) |  | $ | 6,194 |
Deferred tax asset valuation allowance (As adjusted)* | 14,243 |  |  | (4,469 | ) |  | — |  |  | (714 | ) |  | 9,060 |
Year ended December 31, 2012: |  |  |  |  |  |  |  |  |
Allowance for doubtful accounts and sales returns and allowances | $ | 6,978 |  |  | $ | 1,315 |  |  | $ | — |  |  | $ | (1,072 | ) |  | $ | 7,221 |
Deferred tax asset valuation allowance | 32,304 |  |  | (16,979 | ) |  | 477 |  |  | (1,559 | ) |  | 14,243 |
(1) In 2012, $0.5 million of deferred tax liability was reclassified to the valuation allowance with no impact to the consolidated statement of operations. There were no such reclassification adjustments made during 2014 or 2013. *See Note 2 of these consolidated financial statements for discussion of the impact of the change in accounting for the medical device excise tax.

X
- Definition The entire disclosure for any allowance and reserve accounts (their beginning and ending balances, as well as a reconciliation by type of activity during the period). Alternatively, disclosure of the required information may be within the footnotes to the financial statements or a supplemental schedule to the financial statements. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 09 -Article 12 + Details
Name: | us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ValuationAndQualifyingAccountsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration